Recro Reports Inducement Grants for New Staff
April 06, 2021 07:00 ET
|
Recro Pharma, Inc.
MALVERN, Pa., April 06, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
AGC Biologics to Present Their End-to-End Cell and Gene Therapy Offering at ARM’s Meeting on the Mediterranean Conference
April 05, 2021 10:35 ET
|
AGC Biologics
SEATTLE, April 05, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it will be attending Alliance for...
Recro Strengthens Business Development Team to Drive Customer Growth and Diversification
April 05, 2021 07:00 ET
|
Recro Pharma, Inc.
Six Recent Hires Provide Broader Coverage and Expanded Capabilities in the Areas of Sales and Marketing Significant Traction Already Achieved in First Months of 2021 MALVERN, Pa., April 05, 2021 ...
Rentschler Biopharma appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation
March 31, 2021 04:00 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., March 31, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...
Global Pharmaceutical Contract Development and Manufacturing Market Report 2021-2025: Focus on Big Pharma, Small Pharma, Generic Pharma, CRO
March 29, 2021 05:33 ET
|
Research and Markets
Dublin, March 29, 2021 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Development and Manufacturing Market (Pharmaceutical, Biologics, Active Pharma ingredients, tablet, Parenteral, Oral Liquid,...
Rentschler Biopharma and Leukocare extend service offering with joint U.S. site
March 22, 2021 05:00 ET
|
Rentschler Biopharma SE
Leukocare joins Rentschler Biopharma in the U.S., facilitating integrated alliance capabilities and enhanced service for North American clientsClient-focused approach and integration of best-in-class...
Avid Bioservices to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
March 17, 2021 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., March 17, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Global $286 Billion Healthcare Contract Development & Manufacturing Organization Market to 2025: Opportunities with Increasing Collaborations and Investments by CDMOs
March 10, 2021 07:58 ET
|
Research and Markets
Dublin, March 10, 2021 (GLOBE NEWSWIRE) -- The "Global Healthcare Contract Development & Manufacturing Organization Market (2020-2025) by services Geography, Competitive Analysis and the Impact...
Avid Bioservices, Inc. Announces Pricing of $125 Million Offering of Exchangeable Senior Notes
March 10, 2021 00:20 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP) (the “company”), a dedicated biologics contract development and manufacturing organization...
Avid Bioservices, Inc. Announces Proposed $125 Million Offering of Exchangeable Senior Notes
March 08, 2021 17:01 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP) (the “company”), a dedicated biologics contract development and manufacturing organization...